CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting
Abstract Bispecific antibodies (BsAbs) represent an innovative class of off-the-shelf T-cell redirecting agents and are considered among the most promising immunotherapeutic strategies for the treatment of lymphoma. Notably, anti-CD20 × CD3 BsAbs have exhibited substantial monotherapy efficacy in pa...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2025-04-01
|
| Serie: | Journal of Hematology & Oncology |
| Accesso online: | https://doi.org/10.1186/s13045-025-01695-1 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|